Joanne Walker on Muck Rack

Joanne Walker

Verified
London, United Kingdom
As seen in: Journal of Comparative Effectiveness Research, Taylor & Francis Online, Cell Systems, Book News, Future Medicine, Future Oncology, Therapeutic Delivery, Oncology Central
Co-founder & Publishing Director, Becaris Publishing (@_Becaris). Focus on all things real-world evidence, HEOR & #PlainLanguageSummaries. Views are my own.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joanne

Contact Joanne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tracheal Tissue Engineering: Advances and Challenges

|
By Nina D Kosciuszek, Joanne Walker Verified, Heather Wanczyk
| preprints.org
You are already at the latest version Traumatic tracheal injuries and congenital defects can be life threatening. Regenerating the trachea through tissue engineered scaffolds has emerged as an innovative alternative to traditional therapies. At present time, challenges in tracheal regeneration preclude clinical adoption, such as revascularization and promotion of favorable paracrine and immune signaling responses.
Open in Who Shared Issue with article?

Industry news round-up: updates from September 2024

|
By Joanne Walker Verified
| evidencebaseonline.com
Explore the latest advancements in real-world data (RWD), real-world evidence (RWE) and health technology assessment (HTA) as featured on The Evidence Base during September 2024. Proscia introduces comprehensive real-world data offering for precision medicine Proscia’s new RWD solution provides over 10 million pathology images integrated with clinical and genomic data to advance precision medicine.
Open in Who Shared Issue with article?

CMS guidelines finalize process for second cycle of the Medicare Drug Price Negotiation Program

|
By Joanne Walker Verified
| evidencebaseonline.com
The draft guidance outlines how the US Centers for Medicare & Medicaid Services intends to implement the Medicare Drug Price Negotiation Program for the second round of drugs subject to price controls in 2027. Following publication of the draft guidance in May 2024, the US Centers for Medicare & Medicaid Services (CMS) has finalized guidance for the next phase of the Medicare Drug Price Negotiation Program (the ‘Negotiation Program’).
Open in Who Shared Issue with article?
See all 254 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified